Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Johan Areberg

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
Cancer Biotherapy & Radiopharmaceuticals|March 22, 2005
Population biokinetic modeling of thyroid uptake and retention of radioiodineJohan Areberg, H Jönsson, S Mattsson
Basic & Clinical Pharmacology & Toxicology|March 28, 2012
The clinical pharmacokinetics of Lu AA21004 and its major metabolite in healthy young volunteersJohan Areberg, Birgitte Søgaard, Astrid-Maria Højer
Clinical Trials (London, England)|May 3, 2021
Are self-reported and self-monitored adherence good proxies for reaching relevant plasma concentrations?: Experiences from a study of anti-depressants in healthy volunteersKlaus Groes Larsen, Johan Areberg, Daniel Oudin Åström
Cancer Biotherapy & Radiopharmaceuticals|April 2, 2003
Accuracy of the quantification of organ activity from planar gamma camera imagesKristina Norrgren, Sigrid Leide Svegborn, Johan Areberg, et al.
Annals of General Psychiatry|October 1, 2025
Time to efficacious steady state plasma concentrations with slow titration of Vortioxetine drops versus oral tablets: a Pharmacokinetic modelAndrea Fagiolini, Elin H Reines, Anja Farovik, et al.
Clinical Pharmacokinetics|December 1, 2017
Vortioxetine: Clinical Pharmacokinetics and Drug InteractionsGrace Chen, Astrid-Maria Højer, Johan Areberg, et al.
Basic & Clinical Pharmacology & Toxicology|April 29, 2014
Population pharmacokinetic meta-analysis of vortioxetine in healthy individualsJohan Areberg, Kamilla B Petersen, Grace Chen, et al.
Basic & Clinical Pharmacology & Toxicology|August 29, 2024
Population pharmacokinetics of eptinezumab in paediatric patients with migraine and dose selection for phase 3 paediatric migraine studiesJohan Areberg, Monika Rosen, Annika Lindsten, et al.
Clinical Pharmacology and Therapeutics|June 30, 2020
Quantification of In Vivo Metabolic Activity of CYP2D6 Genotypes and Alleles Through Population Pharmacokinetic Analysis of VortioxetineTrine Frederiksen, Johan Areberg, Ellen Schmidt, et al.
Clinical and Translational Science|March 4, 2023
Does ethnicity impact CYP2D6 genotype-phenotype relationships?Trine Frederiksen, Johan Areberg, Ellen Schmidt, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
Cancer Biotherapy & Radiopharmaceuticals|March 22, 2005
Population biokinetic modeling of thyroid uptake and retention of radioiodineJohan Areberg, H Jönsson, S Mattsson
Basic & Clinical Pharmacology & Toxicology|March 28, 2012
The clinical pharmacokinetics of Lu AA21004 and its major metabolite in healthy young volunteersJohan Areberg, Birgitte Søgaard, Astrid-Maria Højer
Clinical Trials (London, England)|May 3, 2021
Are self-reported and self-monitored adherence good proxies for reaching relevant plasma concentrations?: Experiences from a study of anti-depressants in healthy volunteersKlaus Groes Larsen, Johan Areberg, Daniel Oudin Åström
Cancer Biotherapy & Radiopharmaceuticals|April 2, 2003
Accuracy of the quantification of organ activity from planar gamma camera imagesKristina Norrgren, Sigrid Leide Svegborn, Johan Areberg, et al.
Annals of General Psychiatry|October 1, 2025
Time to efficacious steady state plasma concentrations with slow titration of Vortioxetine drops versus oral tablets: a Pharmacokinetic modelAndrea Fagiolini, Elin H Reines, Anja Farovik, et al.
Clinical Pharmacokinetics|December 1, 2017
Vortioxetine: Clinical Pharmacokinetics and Drug InteractionsGrace Chen, Astrid-Maria Højer, Johan Areberg, et al.
Basic & Clinical Pharmacology & Toxicology|April 29, 2014
Population pharmacokinetic meta-analysis of vortioxetine in healthy individualsJohan Areberg, Kamilla B Petersen, Grace Chen, et al.
Basic & Clinical Pharmacology & Toxicology|August 29, 2024
Population pharmacokinetics of eptinezumab in paediatric patients with migraine and dose selection for phase 3 paediatric migraine studiesJohan Areberg, Monika Rosen, Annika Lindsten, et al.
Clinical Pharmacology and Therapeutics|June 30, 2020
Quantification of In Vivo Metabolic Activity of CYP2D6 Genotypes and Alleles Through Population Pharmacokinetic Analysis of VortioxetineTrine Frederiksen, Johan Areberg, Ellen Schmidt, et al.
Clinical and Translational Science|March 4, 2023
Does ethnicity impact CYP2D6 genotype-phenotype relationships?Trine Frederiksen, Johan Areberg, Ellen Schmidt, et al.
Pageof 3